Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the blood pressure lowering effect and safety of
aliskiren in combination with Hydrochlorothiazide (HCTZ) given to diabetic patients with
stage 2 systolic hypertension (mean sitting systolic blood pressure (msSBP) ≥ 160 mm Hg and <
200 mm Hg).